Ying Shang

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

2017-2021 Karolinska Institutet, Ph.D; 2014-2016 Karolinska Institutet, MSc; 2009-2014 Shandong University, MD

Forskningsbeskrivning

My research mainly focuses on risk factors and clinical prognosis of chronic
liver disease, and currently work as part of the Hagström group at the
Department of Medicine, Huddinge (https://ki.se/en/medh/hagstrom-group [1]).
Other research interests involve the epidemiology of diabetes, metabolic
syndrome in general population and certain patients groups.
[1] https://ki.se/en/medh/hagstrom-group

Artiklar

Article: JOURNAL OF HEPATOLOGY. 2025;83(3):643-651
Cause-specific mortality in 13,099 patients with metabolic dysfunction-associated steatotic liver disease in Sweden.
Issa G; Shang Y; Strandberg R; Hagström H; Wester A
Article: JOURNAL OF HEPATOLOGY. 2025;83(2):304-314
Prognostic performance of the two-step clinical care pathway in metabolic dysfunction-associated steatotic liver disease
Yip TC-F; Lee HW; Lin H; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng M-H; Hagstrom H; Boursier J; Calleja JL; Goh GB-B; Chan W-K; Gallego-Duran R; Sanyal AJ; de Ledinghen V; Newsome PN; Fan J-G; Castera L; Lai M; Fournier-Poizat C; Wong GL-H; Pennisi G; Armandi A; Nakajima A; Liu W-Y; Shang Y; de Saint-Loup M; Llop E; Teh KKJ; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS-W; Canivet CM; Romero-Gomez M; Kim SU; Wong VW-S
Article: GASTROENTEROLOGY. 2025;169(2):326-336.e4
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic Perspective.
Liu W-Y; Huang S; Ji H; Kim SU; Yip TC-F; Wong GL-H; Petta S; Tsochatzis E; Nakajima A; Bugianesi E; Goh GB-B; Chan W-K; Romero-Gomez M; Sanyal AJ; Boursier J; Hagström H; Calleja JL; de Lédinghen V; Newsome PN; Fan J-G; Lai M; Castéra L; Lee HW; Pennisi G; Yoneda M; Armandi A; Teh KK-J; Gallego-Durán R; Asgharpour A; de Saint-Loup M; Shang Y; Llop E; Fournier C; Mahgoub S; Lara-Romero C; Canivet CM; Chan MS-W; Lin H; Chen L-L; Targher G; Byrne CD; Du M; Wai-Sun Wong V; Zheng M-H; VCTE-Prognosis Study Group
Article: HEPATOLOGY. 2025;81(5):1501-1511
Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease
Shang Y; Akbari C; Dodd M; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2025;23(5):785-796
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
Feng G; Mozes FE; Ji D; Treeprasertsuk S; Okanoue T; Shima T; Liang H; Tsochatzis E; Chen J; Schattenberg JM; Labenz C; Mahadeva S; Chan WK; Chi X; Delamarre A; de Ledinghen V; Petta S; Bugianesi E; Hagstrom H; Boursier J; Luis Calleja J; Goh GB-B; Gallego-Duran R; Sanyal AJ; Fan J-G; Castera L; Lai M; Harrison SA; Romero-Gomez M; Kim SU; Zhu Y; Ooi G; Shi J; Yoneda M; Nakajima A; Zhang J; Lupsor-Platon M; Zhong B; Cobbold JFL; Ye C-Y; Eddowes PJ; Newsome P; Li J; George J; He F; Song MJ; Tang H; Fan Y; Jia J; Xu L; Lin S; Li Y; Lu Z; Nan Y; Niu J; Yan X; Zhou Y; Liu C; Deng H; Ye Q; Zeng Q-L; Li L; Wang J; Yang S; Lin H; Lee HW; Yip TC-F; Fournier-Poizat C; Wong GL-H; Pennisi G; Armandi A; Liu W-Y; Shang Y; de Saint-Loup M; Llop E; Teh KKJ; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS-W; Canivet CM; Ji F; Xin Y; Chai J; Dong Z; Targher G; Byrne CD; He N; Mi M; Ye F; Wong VW-S; Pavlides M; Zheng M-H
Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2025;134:104-113
Risk of hepatic decompensation or HCC is similar in patients with ALD- and MASLD-cirrhosis: A population-based cohort study
Boeckmans J; Widman L; Shang Y; Strandberg R; Wester A; Schattenberg J; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2025;23(5):816-824.e8
Biomarkers for Prediction of Alcohol-Related Liver Cirrhosis: A General Population-Based Swedish Study of 537,250 Individuals
Jakobsson G; Talback M; Hammar N; Shang Y; Hagstrom H
Article: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2025;61(1):109-121
Timely Follow-Up After a First Diagnosis of Cirrhosis is Associated With Reduced Mortality but No Impact on Rehospitalisations: A Population-Based Cohort of 8852 Patients
Schechter MS; Widman L; Wester A; Shang Y; Stal P; Fortune B; Hagstroem H
Article: LIVER INTERNATIONAL. 2024;44(11):3050-3059
Socioeconomic factors associated with the presence of and outcomes in metabolic dysfunction-associated steatotic liver disease
Nasr P; Shang Y; Wester A; Strandberg R; Widman L; Lazarus JV; Hagstrom H
Article: GUT. 2024;73(11):1883-1892
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
Zhou X-D; Kim SU; Yip TC-F; Petta S; Nakajima A; Tsochatzis E; Boursier J; Bugianesi E; Hagstrom H; Chan WK; Romero-Gomez M; Calleja JL; de Ledinghen V; Castera L; Sanyal AJ; Goh GB-B; Newsome PN; Fan J; Lai M; Fournier-Poizat C; Lee HW; Wong GL-H; Armandi A; Shang Y; Pennisi G; Llop E; Yoneda M; De Saint-Loup M; Canivet CM; Lara-Romero C; Gallego-Duran R; Asgharpour A; Teh KK-J; Mahgoub S; Chan MS-W; Lin H; Liu W-Y; Targher G; Byrne CD; Wong VW-S; Zheng M-H; Group V-PS
Article: LIVER INTERNATIONAL. 2024;44(10):2551-2563
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depression
Astrom H; Shang Y; Hagstrom H; Wester A
Article: DIABETES CARE. 2024;47(6):978-985
Metabolic Syndrome Traits Increase the Risk of Major Adverse Liver Outcomes in Type 2 Diabetes
Shang Y; Grip ET; Modica A; Skroder H; Strom O; Ntanios F; Gudbjornsdottir S; Hagstrom H
Article: LIVER INTERNATIONAL. 2024;44(5):1253-1264
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD
Yang W; Ebrahimi F; Romeo S; Holmer M; Vessby J; Ekstedt M; Ludvigsson JF; Shang Y; Hagstrom H
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(5):1048-1057.e2
Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis
Nasr P; Wester A; Ekstedt M; Strandberg R; Kechagias S; Shang Y; Widman L; Hagstrom H
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2024;331(15):1287-1297
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
Lin H; Lee HW; Yip TC-F; Tsochatzis E; Petta S; Bugianesi E; Yoneda M; Zheng M-H; Hagstrom H; Boursier J; Calleja JL; Goh GB-B; Chan W-K; Gallego-Duran R; Sanyal AJ; de Ledinghen V; Newsome PN; Fan J-G; Castera L; Lai M; Harrison SA; Fournier-Poizat C; Wong GL-H; Pennisi G; Armandi A; Nakajima A; Liu W-Y; Shang Y; de Saint-Loup M; Llop E; Teh KK-J; Lara-Romero C; Asgharpour A; Mahgoub S; Chan MS-W; Canivet CM; Romero-Gomez M; Kim SU; Wong VW-S
Article: GUT. 2024;73(5):835-843
Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes
Wester A; Shang Y; Grip ET; Matthews AA; Hagstrom H
Article: ADDICTION. 2024;119(4):706-716
Disentangling the contributions of alcohol use disorder and alcohol-related liver disease towards dementia: A population-based cohort study
Zhao S; Widman L; Hagstrom H; Shang Y
Article: JHEP REPORTS. 2024;6(2):100915
Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
Akbari C; Dodd M; Stal P; Nasr P; Ekstedt M; Kechagias S; Vessby J; Rorsman F; Zhang X; Wang T; Jemielita T; Fernandes G; Engel SS; Hagstrom H; Shang Y
Article: GASTRO HEP ADVANCES. 2024;3(6):783-792
Lower Incidence of HCC and Other Major Adverse Liver Outcomes in People Living With HIV and Chronic Liver Disease
Michel M; Hagstroem H; Widman L; Nowak P; Shang Y; Schattenberg JM; Wester A
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2024;79(1):glad111
Associations Between Mid- to Late-Life Body Mass Index and Chronic Disease-Free Survival: A Nationwide Twin Study
Guo J; Dove A; Shang Y; Marseglia A; Johnell K; Rizzuto D; Xu W
Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(13):3336-3345.e2
Secondary Prevention of Esophageal Variceal Bleeding Is Often Imperfect: A National, Population-Based Cohort Study of 3592 Patients
Hagstroem H; Shang Y; Tapper EB; Wester A; Widman L
Article: JOURNAL OF HEPATOLOGY. 2023;79(6):1374-1384
Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study
Ebrahimi F; Hagstrom H; Sun J; Bergman D; Shang Y; Yang W; Roelstraete B; Ludvigsson JF
Article: ANNALS OF ONCOLOGY. 2023;34(11):1015-1024
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial
Nilsson K; Klevebro F; Sunde B; Rouvelas I; Lindblad M; Szabo E; Halldestam I; Smedh U; Wallner B; Johansson J; Johnsen G; Aahlin EK; Johannessen H-O; von Doebeln GA; Hjortland GO; Wang N; Shang Y; Borg D; Quaas A; Bartella I; Bruns C; Schroeder W; Nilsson M
Article: UNITED EUROPEAN GASTROENTEROLOGY JOURNAL. 2023;11(9):852-860
Four-fold increased mortality rate in patients with Wilson's disease: A population-based cohort study of 151 patients
Aberg F; Shang Y; Strandberg R; Wester A; Widman L; Hagstrom H
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(11):e0238
Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study
Shang Y; Shen Q; Tapper EB; Wester A; Hagstrom H
Article: HEPATOLOGY COMMUNICATIONS. 2023;7(10):e0279
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort study
Wester A; Shang Y; Stal P; Hagstrom H
Article: LIVER INTERNATIONAL. 2023;43(10):2142-2152
Risk of infections in non-alcoholic fatty liver disease: A nationwide population-based cohort study
Shang Y; Widman L; Ebrahimi F; Ludvigsson JF; Hagstrom H; Wester A
Journal article: JOURNAL OF HEPATOLOGY. 2023;78:s302-s303
Secondary prevention of variceal bleeding is often imperfect: a national, population-based cohort study of 5,018 patients
Hagstrom H; Shang Y; Tapper E; Wester A; Widman L
Article: ALZHEIMERS & DEMENTIA. 2023;19(3):821-830
Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression
Dove A; Marseglia A; Shang Y; Grande G; Vetrano DL; Laukka EJ; Fratiglioni L; Xu W
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2023;78(1):143-150
Association Between Late-Life Weight Change and Dementia: A Population-based Cohort Study
Guo J; Marseglia A; Shang Y; Dove A; Grande G; Fratiglioni L; Xu W
Article: HEPATOLOGY. 2022;76(5):1495-1505
Risk of cardiovascular disease and loss in life expectancy in NAFLD
Shang Y; Nasr P; Widman L; Hagstrom H
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2022;77(10):2093-2101
Healthy Behaviors, Leisure Activities, and Social Network Prolong Disability-Free Survival in Older Adults With Diabetes
Shang Y; Wu W; Dove A; Guo J; Welmer A-K; Rizzuto D; Fratiglioni L; Xu W
Article: NEUROLOGY. 2022;99(6):e574-e582
Nonalcoholic Fatty Liver Disease and Risk of Dementia A Population-Based Cohort Study
Shang Y; Widman L; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2022;57(8):978-983
Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)
Hagstrom H; Shang Y; Wester A; Widman L
Journal article: ALZHEIMERS & DEMENTIA. 2021;17(S10)
Cardiometabolic multimorbidity accelerates cognitive decline and progression to dementia in older adults
Dove A; Marseglia A; Shang Y; Vetrano DL; Grande G; Laukka EJ; Fratiglioni L; Xu W
Article: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. 2021;76(12):2275-2283
Metabolic Syndrome Is Associated With Poor Cognition: A Population-Based Study of 70-Year-Old Adults Without Dementia
Marseglia A; Darin-Mattsson A; Skoog J; Ryden L; Hadarsson-Bodin T; Kern S; Sterner TR; Shang Y; Zettergren A; Westman E; Skoog I
Article: ALZHEIMERS & DEMENTIA. 2021;17(11):1769-1778
The impact of diabetes on cognitive impairment and its progression to dementia
Dove A; Shang Y; Xu W; Grande G; Laukka EJ; Fratiglioni L; Marseglia A
Article: AGE AND AGEING. 2021;50(5):1657-1665
Association of life satisfaction with disability-free survival: role of chronic diseases and healthy lifestyle
Wu W; Shang Y; Calderon-Larranaga A; Rizzuto D; Saadeh M; Dove A; Pan K-Y; Xu W
Article: AGE AND AGEING. 2021;50(5):1666-1674
Individual changes in anthropometric measures after age 60 years: a 15-year longitudinal population-based study
Guo J; Shang Y; Fratiglioni L; Johnell K; Welmer A-K; Marseglia A; Xu W
Article: CLINICAL NUTRITION. 2021;40(8):4838-4844
The Nordic prudent diet prolongs survival with good mental and physical functioning among older adults: The role of healthy lifestyle
Wu W; Shang Y; Dove A; Guo J; Calderon-Larranaga A; Rizzuto D; Xu W
Article: JHEP REPORTS. 2021;3(2):100218
Non-alcoholic fatty liver disease does not increase dementia risk although histology data might improve risk prediction
Shang Y; Nasr P; Ekstedt M; Widman L; Stal P; Hultcrantz R; Kechagias S; Hagstrom H
Article: DIABETES CARE. 2021;44(3):690-698
Not Only Diabetes but Also Prediabetes Leads to Functional Decline and Disability in Older Adults
Shang Y; Fratiglioni L; Vetrano DL; Dove A; Welmer A-K; Xu W
Article: AGE AND AGEING. 2021;50(2):480-487
Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study
Wu W; Xu W; Englund S; Shang Y; Pan K-Y; Rizzuto D
Article: ALZHEIMERS & DEMENTIA. 2021;17(2):191-204
Shared risk and protective factors between Alzheimer's disease and ischemic stroke: A population-based longitudinal study
Wang R; Qiu C; Dintica CS; Shang Y; Larranaga AC; Wang H-X; Xu W
Journal article: ALZHEIMERS & DEMENTIA. 2020;16(S10)
Type 2 diabetes and cardiovascular disease increase the risk of cognitive impairment and accelerate the progression to dementia in Swedish older adults
Dove A; Shang Y; Grande G; Laukka EJ; Fratiglioni L; Xu W; Marseglia A
Article: JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION. 2020;21(10):1458-1463.e2
Role of Cognitive Impairment, Physical Disability, and Chronic Conditions in the Association of Sleep Duration With All-Cause Mortality Among Very Old Adults
Cao Z; Dintica C; Shang Y; Cheng Y; Li S; Yang H; Sun L; Xu W; Wang Y
Article: JOURNAL OF THE AMERICAN HEART ASSOCIATION. 2020;9(18):e017346
Association of Cardiovascular Risk Burden With Risk and Progression of Disability: Mediating Role of Cardiovascular Disease and Cognitive Decline
Cui K; Song R; Xu H; Shang Y; Qi X; Buchman AS; Bennett DA; Xu W
Article: ALZHEIMERS & DEMENTIA. 2020;16(7):1003-1012
Association of diabetes with stroke and post-stroke dementia: A population-based cohort study
Shang Y; Fratiglioni L; Marseglia A; Plym A; Welmer A-K; Wang H-X; Wang R; Xu W
Article: AGING-US. 2020;12(9):8536-8548
The relation of poor mastication with cognition and dementia risk: a population-based longitudinal study
Dintica CS; Marseglia A; Wardh I; Elgestad PS; Rizzuto D; Shang Y; Xu W; Pedersen NL
Article: ALZHEIMERS & DEMENTIA. 2020;16(2):316-325
Leisure activity and social integration mitigate the risk of dementia related to cardiometabolic diseases: A population-based longitudinal study
Wang Z; Marseglia A; Shang Y; Dintica C; Patrone C; Xu W
Article: JOURNAL OF INTERNAL MEDICINE. 2019;286(3):326-340
Natural history of prediabetes in older adults from a population-based longitudinal study
Shang Y; Marseglia A; Fratiglioni L; Welmer A-K; Wang R; Wang H-X; Xu W
Visa fler

Alla övriga publikationer

Letter: JOURNAL OF HEPATOLOGY. 2025;83(2):e95-e97
Potential issues with implementation of EASL-EASD-EASO guidelines on management of MASLD in patients with type 2 diabetes in Sweden
Roeren M; Grip ET; Skroder H; Shang Y; Hagstrom H
Letter: HEPATOLOGY. 2025;81(5):E135-E136
Reply: Should NAFLD be automatically be relabeled as MASLD?
Shang Y; Hagstrom H
Letter: GUT. 2024;73(11):e30
Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD
Shang Y; Akbari C; Dodd M; Nasr P; Vessby J; Rorsman F; Kechagias S; Stal P; Ekstedt M; Hagstrom H
Review: LANCET GASTROENTEROLOGY & HEPATOLOGY. 2024;9(10):944-956
Natural history and progression of metabolic dysfunction-associated steatotic liver disease.
Hagström H; Shang Y; Hegmar H; Nasr P
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2024;22(3):670
Secondary Prevention of Esophageal Variceal Bleeding: Still a Long Way to Go Reply
Hagstrom H; Shang Y; Tapper EB; Wester A; Widman L
Letter: JOURNAL OF HEPATOLOGY. 2024;56(2):e76-e77
99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical
Hagstroem H; Vessby J; Ekstedt M; Shang Y
Letter: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(5):1359-1361.e2
Statins Are Underused in Women With NAFLD After Cardiovascular Events Compared With Matched Control Subjects
Shang Y; Hagstrom H
Editorial comment: HEPATOLOGY. 2023;77(2):350-351
Less is more? Screening for steatosis in older populations
Hagstrom H; Shang Y
Doctoral thesis: 2021
How can older adults combat diabetes to achieve a longer and healthier life?
Shang Y
Letter: JOURNAL OF INTERNAL MEDICINE. 2019;286(6):728-729
Clarifications on blood pressure measurements and the validity of the conclusions
Shang Y; Xu W

Anställningar

Biträdande Lektor, Medicin, Huddinge, Karolinska Institutet, 2024-2029

Examina och utbildning

Medicine Doktorsexamen, Institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska Institutet, 2021
Medicine Masterexamen, Karolinska Institutet, 2016

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI